These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 36928855)

  • 21. Advances and challenges in development of precision psychiatry through clinical metabolomics on mood and psychotic disorders.
    Pedrini M; Cao B; Nani JVS; Cerqueira RO; Mansur RB; Tasic L; Hayashi MAF; McIntyre RS; Brietzke E
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jul; 93():182-188. PubMed ID: 30904564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroimaging-based biomarkers for treatment selection in major depressive disorder.
    Dunlop BW; Mayberg HS
    Dialogues Clin Neurosci; 2014 Dec; 16(4):479-90. PubMed ID: 25733953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human Microbiome and Learning Healthcare Systems: Integrating Research and Precision Medicine for Inflammatory Bowel Disease.
    Chuong KH; Mack DR; Stintzi A; O'Doherty KC
    OMICS; 2018 Feb; 22(2):119-126. PubMed ID: 28282257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer Biomarker Discovery for Precision Medicine: New Progress.
    Zou J; Wang E
    Curr Med Chem; 2019; 26(42):7655-7671. PubMed ID: 30027846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical application of brain imaging for the diagnosis of mood disorders: the current state of play.
    Savitz JB; Rauch SL; Drevets WC
    Mol Psychiatry; 2013 May; 18(5):528-39. PubMed ID: 23546169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating non-coding RNAs in biomarker-guided cardiovascular therapy: a novel tool for personalized medicine?
    de Gonzalo-Calvo D; Vea A; Bär C; Fiedler J; Couch LS; Brotons C; Llorente-Cortes V; Thum T
    Eur Heart J; 2019 May; 40(20):1643-1650. PubMed ID: 29688487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Precision Medicine in Rhinosinusitis.
    Vlastos I; Gkouskou K; Doulaptsi M; Karatzanis A; Prokopakis EP
    Curr Allergy Asthma Rep; 2019 Feb; 19(2):12. PubMed ID: 30793224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Precision medicine and management of rheumatoid arthritis.
    Aletaha D
    J Autoimmun; 2020 Jun; 110():102405. PubMed ID: 32276742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood-Based Biomarker Screening with Agnostic Biological Definitions for an Accurate Diagnosis Within the Dimensional Spectrum of Neurodegenerative Diseases.
    Baldacci F; Lista S; O'Bryant SE; Ceravolo R; Toschi N; Hampel H;
    Methods Mol Biol; 2018; 1750():139-155. PubMed ID: 29512070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Not your average joint: Towards precision medicine in psoriatic arthritis.
    Castillo R; Scher JU
    Clin Immunol; 2020 Aug; 217():108470. PubMed ID: 32473975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biomarkers for personalised treatment in psychiatric diseases.
    Bagdy G; Juhasz G
    Expert Opin Med Diagn; 2013 Sep; 7(5):417-22. PubMed ID: 23875948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Precision Psychiatry: Biomarker-Guided Tailored Therapy for Effective Treatment and Prevention in Major Depression.
    Jones C; Nemeroff CB
    Adv Exp Med Biol; 2021; 1305():535-563. PubMed ID: 33834417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacogenomic Biomarkers and Their Applications in Psychiatry.
    Kam H; Jeong H
    Genes (Basel); 2020 Nov; 11(12):. PubMed ID: 33266292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leveraging innovative technology to generate drug response phenotypes for the advancement of biomarker-driven precision dosing.
    Oni-Orisan A; Srinivas N; Mehta K; Das JL; Nguyen TT; Tison GH; Bauer SR; Burian M; Funk RS; Graham RA;
    Clin Transl Sci; 2021 May; 14(3):784-790. PubMed ID: 33421282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Precision Medicine in Asthma Therapy.
    Principe S; Vijverberg SJH; Abdel-Aziz MI; Scichilone N; Maitland-van der Zee AH
    Handb Exp Pharmacol; 2023; 280():85-106. PubMed ID: 35852633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biomarkers in mood disorders research: developing new and improved therapeutics.
    Niciu MJ; Mathews DC; Ionescu DF; Richards EM; Furey ML; Yuan P; Nugent AC; Henter ID; Machado-Vieira R; Zarate CA
    Rev Psiquiatr Clin; 2014; 41(5):131-134. PubMed ID: 26082563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is there a personalized medicine for mood disorders?
    Bartova L; Berger A; Pezawas L
    Eur Arch Psychiatry Clin Neurosci; 2010 Nov; 260 Suppl 2():S121-6. PubMed ID: 20957381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Managing sepsis in the era of precision medicine: challenges and opportunities.
    Watkins RR; Bonomo RA; Rello J
    Expert Rev Anti Infect Ther; 2022 Jun; 20(6):871-880. PubMed ID: 35133228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Emergence of Precision Urologic Oncology: A Collaborative Review on Biomarker-driven Therapeutics.
    Barbieri CE; Chinnaiyan AM; Lerner SP; Swanton C; Rubin MA
    Eur Urol; 2017 Feb; 71(2):237-246. PubMed ID: 27567210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of treatment outcomes in major depressive disorder.
    Dunlop BW
    Expert Rev Clin Pharmacol; 2015; 8(6):669-72. PubMed ID: 26289221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.